Cardiology
MIV Therapeutics Appoints Internationally Renowned Cardiologist and Chief Executive Officer of Kailash Heart Institute as Clinical Advisor
Published in Cardiovascular Device Liability Week, June 17th, 2007
News; FWB:MIV), a leading developer of next generation biocompatible coatings and advanced drug delivery systems for Cardiovascular stents and other implantable medical devices, has announced that Dr. Daljeet Singh Gambhir, Director of Cardiology and Chief Executive Officer of the Kailash Heart Institute, has been appointed to the Company's Medical Advisory Board and will hold the position of Clinical Advisor to MIVT India.
In the position, Dr. Gambhir will oversee the next phases of MIVT's research and human clinical studies in India as the Company steps up development and commercialization of its novel, biocompatible cardiovascular stents. Dr. Gambhir has been an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Eating Disorders
Anorexia Patients Sue Dallas' Presbyterian Hospital - Abdominal Aortic Aneurysm Immunology
Researchers at INSERM target abdominal aortic aneurysm immunology - Addictive Behavior Therapy
Research from University of Kentucky, Department of Behavioral Science reveals new findings on addictive behavior therapy - Angiology
New angiology research from Taichung Veterans General Hospital, Department of Surgery discussed - Angiology
Researchers at University of Chicago, Department of Medicine target angiology - Angioplasty
Research conducted at Royal Institute of Technology has updated our knowledge about angioplasty - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
